Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia

BackgroundAcute myeloid leukemia (AML) is a clonal malignant disease with poor prognosis and a low overall survival rate. Although many studies on the treatment and detection of AML have been conducted, the molecular mechanism of AML development and progression has not been fully elucidated. The pre...

Full description

Bibliographic Details
Main Authors: Ying Qu, Shuying Zhang, Yanzhang Qu, Heng Guo, Suling Wang, Xuemei Wang, Tianjiao Huang, Hong Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Genetics
Subjects:
AML
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2020.566024/full
id doaj-0da46e2dacf948dcba33aa54d7b9a113
record_format Article
spelling doaj-0da46e2dacf948dcba33aa54d7b9a1132020-11-25T03:38:35ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-10-011110.3389/fgene.2020.566024566024Novel Gene Signature Reveals Prognostic Model in Acute Myeloid LeukemiaYing QuShuying ZhangYanzhang QuHeng GuoSuling WangXuemei WangTianjiao HuangHong ZhouBackgroundAcute myeloid leukemia (AML) is a clonal malignant disease with poor prognosis and a low overall survival rate. Although many studies on the treatment and detection of AML have been conducted, the molecular mechanism of AML development and progression has not been fully elucidated. The present study was designed to pursuit the molecular mechanism of AML using a comprehensive bioinformatics analysis, and build an applicable model to predict the survival probability of AML patients in clinical use.MethodsTo simplify the complicated regulatory networks, we performed the gene co-expression and PPI network based on WGCNA and STRING database using modularization design. Two machine learning methods, A least absolute shrinkage and selector operation (LASSO) algorithm and support vector machine-recursive feature elimination (SVM-RFE), were used to filter the common hub genes by five-fold cross-validation. The candidate hub genes were used to build the predictive model of AML by the cox-proportional hazards analysis, and validated in The Cancer Genome Atlas (TCGA) cohort and ohsu cohort, which were reliable in the experimental verification by qRT-PCR and western blotting in mRNA and protein levels.ResultsThree hub genes, FLT3, CD177 and TTPAL were used to build a clinically applicable model to predict the survival probability of AML patients and divided them into high and low groups. To compare the survival ability of the model with the classical clinical features, we generated the nomogram. The model displayed the most risk points contrast to other clinical characteristics, which was compatible with the data of cox multivariate regression.ConclusionThis study reveal the novel molecular mechanism of AML, and construct a clinical model significantly related to AML patient prognosis. We showed the integrated roles of critical pathways, hub genes associated, which provide potential targets and new research ideas for the treatment and early detection of AML.https://www.frontiersin.org/articles/10.3389/fgene.2020.566024/fullAMLmodularizationmachine learningprognostic modelFLT3
collection DOAJ
language English
format Article
sources DOAJ
author Ying Qu
Shuying Zhang
Yanzhang Qu
Heng Guo
Suling Wang
Xuemei Wang
Tianjiao Huang
Hong Zhou
spellingShingle Ying Qu
Shuying Zhang
Yanzhang Qu
Heng Guo
Suling Wang
Xuemei Wang
Tianjiao Huang
Hong Zhou
Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
Frontiers in Genetics
AML
modularization
machine learning
prognostic model
FLT3
author_facet Ying Qu
Shuying Zhang
Yanzhang Qu
Heng Guo
Suling Wang
Xuemei Wang
Tianjiao Huang
Hong Zhou
author_sort Ying Qu
title Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
title_short Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
title_full Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
title_fullStr Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
title_full_unstemmed Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
title_sort novel gene signature reveals prognostic model in acute myeloid leukemia
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2020-10-01
description BackgroundAcute myeloid leukemia (AML) is a clonal malignant disease with poor prognosis and a low overall survival rate. Although many studies on the treatment and detection of AML have been conducted, the molecular mechanism of AML development and progression has not been fully elucidated. The present study was designed to pursuit the molecular mechanism of AML using a comprehensive bioinformatics analysis, and build an applicable model to predict the survival probability of AML patients in clinical use.MethodsTo simplify the complicated regulatory networks, we performed the gene co-expression and PPI network based on WGCNA and STRING database using modularization design. Two machine learning methods, A least absolute shrinkage and selector operation (LASSO) algorithm and support vector machine-recursive feature elimination (SVM-RFE), were used to filter the common hub genes by five-fold cross-validation. The candidate hub genes were used to build the predictive model of AML by the cox-proportional hazards analysis, and validated in The Cancer Genome Atlas (TCGA) cohort and ohsu cohort, which were reliable in the experimental verification by qRT-PCR and western blotting in mRNA and protein levels.ResultsThree hub genes, FLT3, CD177 and TTPAL were used to build a clinically applicable model to predict the survival probability of AML patients and divided them into high and low groups. To compare the survival ability of the model with the classical clinical features, we generated the nomogram. The model displayed the most risk points contrast to other clinical characteristics, which was compatible with the data of cox multivariate regression.ConclusionThis study reveal the novel molecular mechanism of AML, and construct a clinical model significantly related to AML patient prognosis. We showed the integrated roles of critical pathways, hub genes associated, which provide potential targets and new research ideas for the treatment and early detection of AML.
topic AML
modularization
machine learning
prognostic model
FLT3
url https://www.frontiersin.org/articles/10.3389/fgene.2020.566024/full
work_keys_str_mv AT yingqu novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT shuyingzhang novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT yanzhangqu novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT hengguo novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT sulingwang novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT xuemeiwang novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT tianjiaohuang novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
AT hongzhou novelgenesignaturerevealsprognosticmodelinacutemyeloidleukemia
_version_ 1724541601002291200